- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
Ligand id: 47
View more information in the IUPHAR Pharmacology Education Project: olanzapine
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|Approved drug?||Yes (EMA & FDA (1996))|
|International Nonproprietary Names|
|LY-170053 | Zyprexa®|
|Olanzapine displays affinity for numerous receptors from the serotonin, histamine, alpha adrenergic, dopamine and muscarinic acetylcholine receptor families. Its antipsychotic properties are believed to arise from its antagonism of the dopamine D2 and 5-HT2A receptors.
Marketed formulations may contain olanzapine pamoate (PubChem CID 12085238). Olanzapine is represented on some databases with some of the double bonds in a different position. See CHEBI:7735 and CHEMBL715.
|CAS Registry No.||132539-06-1|
|GtoPdb PubChem SID||135650756|
|Search Google for chemical match using the InChIKey||WXPNDRBBWZMPQG-UHFFFAOYSA-N|
|Search Google for chemicals with the same backbone||WXPNDRBBWZMPQG|
|Search PubMed clinical trials||olanzapine|
|Search PubMed titles||olanzapine|
|Search PubMed titles/abstracts||olanzapine|
|Search UniChem for chemical match using the InChIKey||WXPNDRBBWZMPQG-UHFFFAOYSA-N|
|Search UniChem for chemicals with the same backbone||WXPNDRBBWZMPQG|
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.✖
Cat. No. 4349